From body bags for rapid cooling to “prescriptions” for air conditioners, doctors are preparing for a future of extreme heat linked to climate change.
The FTC’s ban on noncompete agreements, approved Tuesday, was immediately challenged in a lawsuit filed in the Eastern District of Texas.
Takeda Pharmaceuticals has left BIO, the fourth departure of a major member since December, the company confirmed.
Genetic evidence of H5N1 bird flu virus has been found in grocery store milk, according to the FDA. In this video, STAT explains what is…
Biogen on Wednesday reported first-quarter earnings that beat Wall Street expectations largely on reduced expenses.
As the Covid-19 experience showed, trying to address IP during a pandemic doesn’t work, and voluntary sharing of IP during a pandemic doesn’t work.
The authors of a new study argue the heralded arrival of biosimilars failed to fully deliver on their promise.
Costs for the U.S. health care system and the federal government will climb thanks to weight loss drugs, two new reports show.
It takes great minds with a lot of heart to find a cure for diseases like Duchenne muscular dystrophy.
The first signs that H5N1 avian flu was starting to spread from person to person would trigger a race to produce massive amounts of vaccine.
The agency simply doesn’t have enough resources to challenge but 1% of hospital mergers, so they continue to result in less competition and higher prices.
